A Study to Assess the PK, PD, Safety and Immunogenicity of Single IV Infusion of BCD-264 and Darzalex in Healthy Subjects
Clinical trial NCT05974969 · COMPLETED
Trial details
- NCT number
- NCT05974969
- Sponsor
- Biocad
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2023-08-15
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.